NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 25, 2026 — Soligenix (SNGX) featured in Zacks research report highlighting HyBryte Phase 3 trial for CTCL and SGX945 for Behçet's disease. Key clinical milestones expected in 2026.
March 25, 2026 — Engle Services offers AC repair Alabama tips for summer breakdowns: check thermostats, filters, and circuit breakers. Learn emergency steps to stay cool and safe.
March 25, 2026 — VolitionRx announces 95% accurate liquid biopsy for early cancer detection using Capture-Seq technology. Study shows 94-96% detection rates for stage I-II cancers targeting $36B market.
March 25, 2026 — GeoVax completes release testing for GEO-MVA mpox/smallpox vaccine, advancing toward Phase 3 trial. Could address global supply gaps and enhance biodefense preparedness.
March 25, 2026 — Upland Software's AccuRoute offers HIPAA-compliant fax software for secure document delivery in healthcare, legal, and finance, integrating with Content Capture Software to ensure data protection and regulatory compliance.
March 25, 2026 — Study links placental abruption in pregnancy to 4.6x higher risk of child cardiovascular death by age 28. Researchers urge lifelong heart monitoring for affected children.
March 25, 2026 — Emerald Coast Foot and Ankle Center in Pensacola, FL, provides expert podiatric care with personalized treatment plans for foot pain, bunions, and surgery under Dr. Carl Speer.
March 25, 2026 — Upland InterFAX enhances healthcare data security with HIPAA-compliant cloud fax solutions, eliminating physical fax machines while protecting patient information and improving care efficiency.
March 24, 2026 — BioStem Technologies reports Q4 2025 results with 97% gross margin, completes BioTissue acquisition to expand into hospital markets despite reimbursement challenges and competitive pressures.
March 24, 2026 — Soligenix announces new HyBryte™ trial data for CTCL treatment to be presented at dermatology conference. Learn about this novel photodynamic therapy for rare cancer.
March 24, 2026 — HeartBeam partners with Mount Sinai to develop AI-based ECG algorithms for heart attack risk assessment and personalized cardiac monitoring, advancing remote healthcare technology.
March 24, 2026 — Study finds ChatGPT's Health chatbot gave erroneous medical advice 50% of the time, recommending delayed care when immediate attention was needed. Raises concerns about AI safety in healthcare applications.
March 24, 2026 — Misinformation threatens promising mRNA cancer vaccine development. BioMedWire reports on how false information could undermine medical breakthroughs and affect companies like CNS Pharmaceuticals.
March 24, 2026 — Landmark study shows proton therapy achieves 90.9% 5-year survival for throat cancer vs. 81% for traditional radiation. LIXTE Biotechnology expands into this advancing field.
March 24, 2026 — Earth Science Tech launches MyOnlineConsultation.com telehealth platform through MOCTeledoc, integrating clinical staffing, technology & pharmacy fulfillment to expand its healthcare ecosystem.
March 24, 2026 — Oncotelic Therapeutics subsidiary Sapu Nano to present its Deciparticle nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026, seeking partnerships for cancer drug development.
March 24, 2026 — Mushrooms Inc. achieves proof of concept for mycelium-based infection detection technology and completes MycoLab.ai AI platform beta testing, reshaping strategic options.
March 24, 2026 — VGTEL enters strategic discussions to acquire breakthrough health-tech app from 4biddenknowledge. Emerging wellness platform combines data-driven insights with consciousness research.
March 24, 2026 — Lantern Pharma (LTRN) announces webcast for Q4 & FY2025 results on March 30. CEO Panna Sharma to discuss financial performance & AI-driven RADR platform updates for cancer drug development.
March 24, 2026 — Soligenix featured in Zacks research report highlighting HyBryte Phase 3 CTCL trial and SGX945 for Behçet's disease. Key clinical milestones expected through 2026.